The Pathogenesis of Raised Intraocular Pressure in Uveitis

References

• Siddique SS, Suelves AM, Baheti U, Foster CS. Glaucoma and uveitis. Surv Ophthalmol 2013;58:1–10
   Google Scholar
• Neri P, Azuara-Blanco A, Forrester JV. Incidence of glaucoma in patients with uveitis. J Glaucoma 2004;13:461–465
   PubMed Web of Science ®Google Scholar
• Moorthy R, Mermoud A, Baerveldt G, Minckler D, Lee P, Rao N. Glaucoma associated with uveitis. Surv Ophthalmol 1997;41:361–394
   PubMed Web of Science ®Google Scholar
• Beer J, Die Lehre v. d. Augenkrankheiten. Vienna 1813;1:633
   Google Scholar
• Merayo-Lloves J, Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS. Secondary glaucoma in patients with uveitis. Ophthalmologica 1999;213:300–304
   PubMed Web of Science ®Google Scholar
• Takahashi T, Ohtani S, Miyata K, Miyata N, Shirato S, Mochizuki M. A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol 2002;46:556–562
   PubMed Web of Science ®Google Scholar
• Elliot R. A treatise on glaucoma. London: Oxford Med Publ; 1918
   Google Scholar
• Jones III RD. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol 2006;17:163–167
   PubMed Web of Science ®Google Scholar
• Toris CB, Pederson JE. Aqueous humor dynamics in experimental iridocyclitis. Invest Ophthalmol Vis Sci 1987;28:477–481
   PubMed Web of Science ®Google Scholar
• Bill A, Phillips CI. Uveoscleral drainage of aqueous humour in human eyes. Exp Eye Res 1971;12:275–281
   PubMed Web of Science ®Google Scholar
• Bill A. Aqueous humor dynamics in monkeys (Macaca irus and Cercopithecus ethiops). Exp Eye Res 1971;11:195–206
   PubMed Web of Science ®Google Scholar
• Toris C, Camras C, Yablonski M. Effects of PhXA41, a new prostaglandin F2a analogue, on aqueous humor dynamics in human eyes. Ophthalmology 1993;100:1297–1304
   PubMed Web of Science ®Google Scholar
• Toris CB, Yablonski ME, Wang Y-L, Camras CB. Aqueous humor dynamics in the aging human eye. Am J Ophthalmol 1999;127:407–412
   PubMed Web of Science ®Google Scholar
• Toris CB, Koepsell SA, Yablonski ME, Camras CB. Aqueous humor dynamics in ocular hypertensive patients. J Glaucoma 2002;11:253–258
   PubMed Web of Science ®Google Scholar
• Mermoud A, Baerveldt G, Mickler DS, Wu GS, Rao NA. Animal model for uveitic glaucoma. Graefes Arch Clin Exp Ophthalmol 1994;232:553–560
   PubMed Web of Science ®Google Scholar
• Howes EJ, Cruse VK. The structural basis of altered vascular permeability following introcular inflammation. Arch Ophthalmol 1978;96:1668–1676
   PubMed Web of Science ®Google Scholar
• Johnson D, Liesegang TJ, Brubaker RF. Aqueous humor dynamics in Fuchs’ uveitis syndrome. Am J Ophthalmol 1983;95:783–787
   PubMed Web of Science ®Google Scholar
• Eakins K. Prostaglandin and non-prostaglandin mediated breakdown of the blood-aqueous barrier. Exp Eye Res 1977;25:483
   PubMed Web of Science ®Google Scholar
• Horsley M, Chen T. The use of prostaglandin analogs in the uveitic patient. Semin Ophthalmol 2011;26:285–289
   PubMed Web of Science ®Google Scholar
• Eakins K, Whitelocke R, Bennett A, Martenet A. Prostaglandin-like activity in ocular inflammation. Br J Med 1972;3:452–453
   PubMed Web of Science ®Google Scholar
• Herbort C, Mermoud A, Schnyder C, Pittet N. Anti-inflammatory effect of diclofenac drops after argon laser trabeculoplasty. Arch Ophthalmol 1993;111:481–483
   PubMed Web of Science ®Google Scholar
• Hayashi M, Yablonski ME, Bito LZ. Eicosanoids as a new class of ocular hypotensive agents. 2. Comparison of the apparent mechanism of the ocular hypotensive effects of A and F type prostaglandins. Invest Ophthalmol Vis Sci 1987;28:1639–1643
   PubMed Web of Science ®Google Scholar
• Toris CB, Gabelt BT, Kaufman PL. Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Surv Ophthalmol 2008;53:S107–S120
   PubMed Web of Science ®Google Scholar
• Lim KS, Nau CB, O’Byrne MM, Hodge DO, Toris CB, McLaren JW, et al. Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study. Ophthalmology 2008;115:790.e4–795.e4
   PubMed Web of Science ®Google Scholar
• Christiansen GA, Nau CB, McLaren JW, Johnson DH. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma. Ophthalmology 2004;111:1658–1662
   PubMed Web of Science ®Google Scholar
• Ladas JG, Yu F, Loo R, Davis JL, Coleman AL, Levinson RD, et al. Relationship between aqueous humor protein level and outflow facility in patients with uveitis. Invest Ophthalmol Vis Sci 2001;42:2584–2588
   PubMed Web of Science ®Google Scholar
• Epstein DL, Hashimoto JM, Grant WM. Serum obstruction of aqueous outflow in enucleated eyes. Am J Ophthalmol 1978;86:101–105
   PubMed Web of Science ®Google Scholar
• Peretz WL, Tomasi T. Aqueous humor proteins in uveitis. Immunoelectrophoretic and gel diffusion studies on normal and pathological human aqueous humor. Arch Ophthalmol 1961;65:20–23
   PubMed Web of Science ®Google Scholar
• Epstein DL, Jedziniak JA, Grant WM. Obstruction of aqueous outflow by lens particles and by heavy-molecular-weight soluble lens proteins. Invest Ophthalmol Vis Sci 1978;17:272–277
   PubMed Web of Science ®Google Scholar
• Altamirano D, Mermoud A, Pittet N, van Melle G, Herbort CP. Aqueous humor analysis after Nd:YAG laser capsulotomy with the laser flare-cell meter. J Cataract Refract Surg 1992;18:554–558
   PubMed Web of Science ®Google Scholar
• Ge J, Wand M, Chiang R, Paranhos A, Shields MB. Long-term effect of Nd:YAG laser posterior capsulotomy on intraocular pressure. Arch Ophthalmol 2000;118:1334–1337
   PubMed Web of Science ®Google Scholar
• Lambrou FH, Vela MA, Woods W. Obstruction of the trabecular meshwork by retinal rod outer segments. Arch Ophthalmol 1989;107:742–745
   PubMed Web of Science ®Google Scholar
• Fiore PM, Melamed S, Epstein DL. Trabecular precipitates and elevated intraocular pressure following argon laser trabeculoplasty. Ophthalmic Surg 1989;20:697–701
   PubMedGoogle Scholar
• Cohen RG, Wu HK, Schuman JS. Glaucoma with inflammatory precipitates on the trabecular meshwork: a report of Grant’s syndrome with ultrasound biomicroscopy of precipitates. J Glaucoma 1996;5:266–270
   PubMed Web of Science ®Google Scholar
• Richardson TM, Hutchinson BT, Grant WM. The outflow tract in pigmentary glaucoma: a light and electron microscopic study. Arch Ophthalmol 1977;95:1015–1025
   PubMed Web of Science ®Google Scholar
• Hogan MJ, Kimura SJ, Thygeson P. Pathology of herpes simplex kerato-iritis. Trans Am Ophthalmol Soc 1963;61:75–99
   PubMedGoogle Scholar
• Townsend WM, Kaufman HE. Pathogenesis of glaucoma and endothelial changes in herpetic kerato-uveitis in rabbits. Am J Ophthalmol 1971;71:904–910
   PubMed Web of Science ®Google Scholar
• Falcon MG, Williams HP. Herpes simplex kerato-uveitis and glaucoma. Trans Ophthalmol Soc UK 1978;98:101–104
   PubMedGoogle Scholar
• Horai R, Caspi RR. Cytokines in autoimmune uveitis. J Interferon Cytokine Res 2011;31:733–744
   PubMed Web of Science ®Google Scholar
• Deschenes J, Char D, Kaleta S. Activated T lymphocytes in uveitis. Br J Ophthalmol 1988;72:83–87
   PubMed Web of Science ®Google Scholar
• Murray P, Clay C, Mappin C, Salmon M. Molecular analysis of resolving immune responses in uveitis. Clin Exp Immunol 1999;117:455–461
   PubMed Web of Science ®Google Scholar
• Murphy CC, Duncan L, Forrester J V, Dick AD. Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis. Br J Ophthalmol 2004;88:412–416
   PubMed Web of Science ®Google Scholar
• Rao NA, Wu GS. Free radical mediated photoreceptor damage in uveitis. Prog Retin Eye Res 2000;19:41–68
   PubMed Web of Science ®Google Scholar
• Sorkhabi R, Ghorbanihaghjo A, Javadzadeh A, Rashtchizadeh N, Moharrery M. Oxidative DNA damage and total antioxidant status in glaucoma patients. Mol Vis 2011;17:41–46
   PubMed Web of Science ®Google Scholar
• Oshida E, Matsumoto Y, Arai K. Free radicals in the aqueous humor of patients with glaucoma. Clin Ophthalmol 2010;4:653–660
   PubMedGoogle Scholar
• Rao PV, Deng PF, Kumar J, Epstein DL. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci 2001;42:1029–1037
   PubMed Web of Science ®Google Scholar
• Rao PV, Deng P, Maddala R, Epstein DL, Li C-Y, Shimokawa H. Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow. Mol Vis 2005;11:288–297
   PubMed Web of Science ®Google Scholar
• Oguz E, Alasehirli B, Pehlivan Y, Onat AM, Oztuzcu S, Ozkara E, et al. Association between Rho-kinase (ROCK2) gene polymorphisms and Behçet’s disease. Transl Res 2012;160:428–434
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Sandman R, Ryder MI, Friberg TR. Angiotensin-converting enzyme activity in human aqueous humor. Arch Ophthalmol 1985;103:34–36
   PubMed Web of Science ®Google Scholar
• Shah GB, Sharma S, Mehta AA, Goyal RK. Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma. J Cardiovasc Pharmacol 2000;36:169–175
   PubMed Web of Science ®Google Scholar
• Mehta A, Iyer L, Parmar S, Shah G, Goyal R. Oculohypotensive effect of perindopril in acute and chronic models of glaucoma in rabbits. Can J Physiol Pharmacol 2010;88:595–600
   PubMed Web of Science ®Google Scholar
• Hirooka K, Shiraga F. Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma. Clin Ophthalmol 2007;1:217–223
   PubMedGoogle Scholar
• Armaly MF, Becker B. Intraocular pressure response to topical corticosteroids. Fed Proc 1965;24:1274–1278
   PubMedGoogle Scholar
• Becker B. Intraocular pressure response to topical corticosteroids. Invest Ophthalmol 1965;4:198–205
   PubMedGoogle Scholar
• Tripathi RC, Parapuram SK, Tripathi BJ, Zhong Y, Chalam KV. Corticosteroids and glaucoma risk. Drugs Aging 1999;15:439–450
   PubMed Web of Science ®Google Scholar
• Kersey JP, Broadway DC. Corticosteroid-induced glaucoma: a review of the literature. Eye (Lond) 2006;20:407–416
   PubMed Web of Science ®Google Scholar
• Razeghinejad MR, Katz LJ. Steroid-induced iatrogenic glaucoma. Ophthalmic Res 2012;47:66–80
   PubMed Web of Science ®Google Scholar
• Renfro L, Snow JS. Ocular effects of topical and systemic steroids. Dermatol Clin 1992;10:505–512
   PubMed Web of Science ®Google Scholar
• Yue BY. The extracellular matrix and its modulation in the trabecular meshwork. Surv Ophthalmol 1996;40:379–390
   Google Scholar
• Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. I. The effect of dexamethasone in the normal eye. Arch Ophthalmol 1963;70:482–491
   PubMed Web of Science ®Google Scholar
• François J. Corticosteroid glaucoma. Ann Ophthalmol 1977;9:1075–1080
   PubMed Web of Science ®Google Scholar
• François J. Corticosteroid glaucoma. Ophthalmologica 1984;188:76–81
   PubMed Web of Science ®Google Scholar
• Knepper PA, Collins JA, Frederick R. Effects of dexamethasone, progesterone, and testosterone on IOP and GAGs in the rabbit eye. Invest Ophthalmol Vis Sci 1985;26:1093–1100
   PubMed Web of Science ®Google Scholar
• Johnson DH, Knepper PA. Microscale analysis of the glycosaminoglycans of human trabecular meshwork: a study in perfusion cultured eyes. J Glaucoma 1994;3:58–69
   PubMedGoogle Scholar
• Stone EM. Identification of a gene that causes primary open angle glaucoma. Science 1997;275:668–670
   PubMed Web of Science ®Google Scholar
• Fautsch MP, Bahler CK, Jewison DJ, Johnson DH. Recombinant TIGR/MYOC increases outflow resistance in the human anterior segment. Invest Ophthalmol Vis Sci 2000;41:4163–4168
   PubMed Web of Science ®Google Scholar
• Fingert JH, Clark AF, Craig JE, Alward WL, Snibson GR, McLaughlin M, et al. Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension. Invest Ophthalmol Vis Sci 2001;42:145–152
   PubMed Web of Science ®Google Scholar
• Lo WR. Tissue differential microarray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma. Invest Ophthalmol Vis Sci 2003;44:473–485
   PubMed Web of Science ®Google Scholar
• Friedman DS, Holbrook JT, Ansari H, Alexander J, Burke A, Reed SB, et al. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Ophthalmology 2013;120:1571–1579
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Pavan-Langston D, Tada R, Yamamoto R, Kinoshita S, Nishida K, et al. Possible role of herpes simplex virus in the origin of Posner-Schlossman syndrome. Am J Ophthalmol 1995;119:796–798
   PubMed Web of Science ®Google Scholar
• Hedayatfar A, Chee S-P. Posner-Schlossman syndrome associated with cytomegalovirus infection: a case series from a non-endemic area. Int Ophthalmol 2014;34:1123–1129
   PubMed Web of Science ®Google Scholar
• Rodier-Bonifas C, Cornut P-L, Billaud G, Lina B, Burillon C, Denis P. [Cytomegalovirus research using polymerase chain reaction in Posner-Schlossman syndrome]. J Fr Ophtalmol 2011;34:24–29
   PubMed Web of Science ®Google Scholar
• Smith SL, Pruitt CA, Sine CS, Hudgins AC, Stewart WC. Latanoprost 0.005% and anterior segment uveitis. Acta Ophthalmol Scand 1999;77:668–672
   PubMedGoogle Scholar
• Warwar RE, Bullock JD, Ballal D. Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients. Ophthalmology 1998;105:263–268
   PubMed Web of Science ®Google Scholar
• Fechtner RD, Khouri AS, Zimmerman TJ, Bullock J, Feldman R, Kulkarni P, et al. Anterior uveitis associated with latanoprost. Am J Ophthalmol 1998;126:37–41
   PubMed Web of Science ®Google Scholar
• Packer M, Fine IH, Hoffman RS. Bilateral nongranulomatous anterior uveitis associated with bimatoprost. J Cataract Refract Surg 2003;29:2242–2243
   PubMed Web of Science ®Google Scholar
• Kumarasamy M, Desai SP. Anterior uveitis is associated with travoprost. BMJ 2004;329:205
   PubMed Web of Science ®Google Scholar
• Aydin S, Ozcura F. Corneal oedema and acute anterior uveitis after two doses of travoprost. Acta Ophthalmol Scand 2007;85:693–694
   PubMedGoogle Scholar
• Kessler C, Christ T. Incidence of uveitis in glaucoma patients using metipranolol. J Glaucoma 1993;2:166–170
   PubMedGoogle Scholar
• Chang JH, McCluskey P, Missotten T, Ferrante P, Jalaludin B, Lightman S. Use of ocular hypotensive prostaglandin analogues in patients with uveitis: does their use increase anterior uveitis and cystoid macular oedema?. Br J Ophthalmol 2008;92:916–921
   PubMed Web of Science ®Google Scholar
• Markomichelakis NN, Kostakou A, Halkiadakis I, Chalkidou S, Papakonstantinou D, Georgopoulos G. Efficacy and safety of latanoprost in eyes with uveitic glaucoma. Graefes Arch Clin Exp Ophthalmol 2009;247:775–780
   PubMed Web of Science ®Google Scholar
• Sung VCT, Barton K. Management of inflammatory glaucomas. Curr Opin Ophthalmol 2004;15:136–140
   PubMedGoogle Scholar
• Stavrou P, Murray PI. Long-term follow-up of trabeculectomy without antimetabolites in patients with uveitis. Am J Ophthalmol 1999;128:434–439
   PubMed Web of Science ®Google Scholar
• Towler HM, Bates AK, Broadway DC, Lightman S. Primary trabeculectomy with 5-fluorouracil for glaucoma secondary to uveitis. Ocul Immunol Inflamm 1995;3:163–170
   PubMedGoogle Scholar
• Towler HM, McCluskey P, Shaer B, Lightman S. Long-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma. Ophthalmology 2000;107:1822–1828
   PubMed Web of Science ®Google Scholar
• Jampel HD, Jabs DA, Quigley HA. Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. Am J Ophthalmol 1990;109:168–173
   PubMed Web of Science ®Google Scholar
• Novak-Laus K, Mandić Z, Iveković R, Korsić J, Tedeschi-Reiner E, Masnec-Paskvalin S, et al. Trabeculectomy with mitomycin C in glaucoma associated with uveitis. Coll Antropol 2005;29:17–20
   PubMed Web of Science ®Google Scholar
• Yalvac IS, Sungur G, Turhan E, Eksioglu U, Duman S. Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease. J Glaucoma 2004;13:450–453
   PubMed Web of Science ®Google Scholar
• Auer C, Mermoud A, Herbort CP. Deep sclerectomy for the management of uncontrolled uveitic glaucoma: preliminary data. Klin Monbl Augenheilkd 2004;221:339–342
   PubMed Web of Science ®Google Scholar
• Anand N. Deep sclerectomy with mitomycin C for glaucoma secondary to uveitis. Eur J Ophthalmol 2011;21:708–714
   PubMed Web of Science ®Google Scholar
• Souissi K, El Afrit MA, Trojet S, Kraiem A. [Deep sclerectomy for the management of uveitic glaucoma]. J Fr Ophtalmol 2006;29:265–268
   PubMed Web of Science ®Google Scholar
• Ang GS, Varga Z, Shaarawy T. Postoperative infection in penetrating versus non-penetrating glaucoma surgery. Br J Ophthalmol 2010;94:1571–1576
   PubMed Web of Science ®Google Scholar
• Da Mata A, Burk SE, Netland PA, Baltatzis S, Christen W, Foster CS. Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology 1999;106:2168–2172
   PubMed Web of Science ®Google Scholar
• Gil-Carrasco F, Salinas-VanOrman E, Recillas-Gispert C, Paczka JA, Gilbert ME, Arellanes-García L. Ahmed valve implant for uncontrolled uveitic glaucoma. Ocul Immunol Inflamm 1998;6:27–37
   PubMed Web of Science ®Google Scholar
• Papadaki TG, Zacharopoulos IP, Pasquale LR, Christen WB, Netland PA, Foster CS. Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol 2007;144:62–69
   PubMed Web of Science ®Google Scholar
• Bettis DI, Morshedi RG, Chaya C, Goldsmith J, Crandall A, Zabriskie N. Trabeculectomy with mitomycin C or Ahmed valve implantation in eyes with uveitic glaucoma. J Glaucoma 2014. [Epub ahead of print]. doi:10.1097/IJG.0000000000000195
   PubMed Web of Science ®Google Scholar
• Murphy CC, Burnett CAM, Spry PGD, Broadway DC, Diamond JP. A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 2003;87:1252–1257
   PubMed Web of Science ®Google Scholar
• Toris CB, Yablonski ME, Wang YL, Hayashi M. Prostaglandin A2 increases uveoscleral outflow and trabecular outflow facility in the cat. Exp Eye Res 1995;61:649–657
   PubMed Web of Science ®Google Scholar
• Fortuna E, Cervantes-Castañeda RA, Castañeda-Cervantes RA, Bhat P, Doctor P, Foster CS. Flare-up rates with bimatoprost therapy in uveitic glaucoma. Am J Ophthalmol 2008;146:876–882
   PubMed Web of Science ®Google Scholar